Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation (SRS) in Patients With 5-20 Brain Metastases: A Phase III, Randomized Clinical Trial

NCT03075072 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT03075072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03075072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation (SRS) in Patients With 5-20 Brain Metastases: A Phase III, Randomized Clinical Trial
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 10, 2017
Completion date
September 30, 2027
Enrollment
196 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases